Coherus BioSciences, Inc. (CHRS)
USD 0.8
(2.35%)
USD 0.8
(2.35%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -237.89 Million USD | 27.17% |
| 2022 | -326.62 Million USD | -6.63% |
| 2021 | -306.32 Million USD | -331.63% |
| 2020 | 132.24 Million USD | 47.21% |
| 2019 | 89.83 Million USD | 142.91% |
| 2018 | -209.33 Million USD | 12.11% |
| 2017 | -238.17 Million USD | -87.04% |
| 2016 | -127.33 Million USD | 42.96% |
| 2015 | -223.26 Million USD | -156.23% |
| 2014 | -87.13 Million USD | -62.46% |
| 2013 | -53.63 Million USD | -62.44% |
| 2012 | -33.01 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 102.87 Million USD | 229.15% |
| 2024 Q2 | -12.92 Million USD | -112.56% |
| 2023 Q4 | -79.65 Million USD | -100.94% |
| 2023 FY | -237.89 Million USD | 27.17% |
| 2023 Q1 | -74.78 Million USD | -12.88% |
| 2023 Q2 | -42.86 Million USD | 42.67% |
| 2023 Q3 | -39.64 Million USD | 7.53% |
| 2022 Q4 | -66.24 Million USD | 28.65% |
| 2022 Q3 | -92.85 Million USD | -64.96% |
| 2022 Q1 | -111.24 Million USD | -143.29% |
| 2022 Q2 | -56.28 Million USD | 49.4% |
| 2022 FY | -326.62 Million USD | -6.63% |
| 2021 Q2 | -29.9 Million USD | 82.71% |
| 2021 Q3 | -38.52 Million USD | -28.86% |
| 2021 FY | -306.32 Million USD | -331.63% |
| 2021 Q4 | -45.72 Million USD | -18.68% |
| 2021 Q1 | -172.94 Million USD | -1881.49% |
| 2020 Q3 | 27.93 Million USD | -52.68% |
| 2020 Q4 | 9.7 Million USD | -65.25% |
| 2020 FY | 132.24 Million USD | 47.21% |
| 2020 Q1 | 35.57 Million USD | -9.32% |
| 2020 Q2 | 59.03 Million USD | 65.95% |
| 2019 Q4 | 39.22 Million USD | -16.61% |
| 2019 FY | 89.83 Million USD | 142.91% |
| 2019 Q3 | 47.04 Million USD | 99.61% |
| 2019 Q2 | 23.56 Million USD | 217.81% |
| 2019 Q1 | -20 Million USD | 68.04% |
| 2018 Q2 | -43.63 Million USD | 1.49% |
| 2018 Q1 | -44.29 Million USD | 9.72% |
| 2018 FY | -209.33 Million USD | 12.11% |
| 2018 Q4 | -62.59 Million USD | -6.44% |
| 2018 Q3 | -58.8 Million USD | -34.76% |
| 2017 Q2 | -55.33 Million USD | 26.0% |
| 2017 Q3 | -58.98 Million USD | -6.6% |
| 2017 Q4 | -49.06 Million USD | 16.82% |
| 2017 FY | -238.17 Million USD | -87.04% |
| 2017 Q1 | -74.77 Million USD | 1.51% |
| 2016 Q1 | -65.38 Million USD | -24.81% |
| 2016 FY | -127.33 Million USD | 42.96% |
| 2016 Q4 | -75.92 Million USD | -190.45% |
| 2016 Q3 | 83.93 Million USD | 219.97% |
| 2016 Q2 | -69.96 Million USD | -7.0% |
| 2015 Q4 | -52.39 Million USD | 26.56% |
| 2015 Q2 | -58.81 Million USD | -44.41% |
| 2015 Q1 | -40.72 Million USD | -39.79% |
| 2015 Q3 | -71.33 Million USD | -21.3% |
| 2015 FY | -223.26 Million USD | -156.23% |
| 2014 Q4 | -29.13 Million USD | -270.1% |
| 2014 FY | -87.13 Million USD | -62.46% |
| 2014 Q2 | -24.95 Million USD | 0.85% |
| 2014 Q1 | -25.17 Million USD | -72.5% |
| 2014 Q3 | -7.87 Million USD | 68.46% |
| 2013 Q4 | -14.59 Million USD | 32.05% |
| 2013 Q1 | -8.86 Million USD | 0.0% |
| 2013 FY | -53.63 Million USD | -62.44% |
| 2013 Q3 | -21.47 Million USD | -146.56% |
| 2013 Q2 | -8.7 Million USD | 1.73% |
| 2012 FY | -33.01 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -146.39 Million USD | -62.497% |
| Alkermes plc | 355.75 Million USD | 166.869% |
| Agenus Inc. | -245.76 Million USD | 3.202% |
| Aptorum Group Limited | -2.82 Million USD | -8322.008% |
| Ardelyx, Inc. | -66.06 Million USD | -260.077% |
| Dyadic International, Inc. | -6.79 Million USD | -3400.749% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -25315.812% |
| Lantern Pharma Inc. | -15.96 Million USD | -1390.408% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -1150.163% |
| Novavax, Inc. | -545.06 Million USD | 56.355% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -308.097% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -222.391% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -1182.707% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -2282.255% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -303.325% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | 36.33% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -877.399% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -537.097% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -44.55% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -224.338% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -1072.402% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -282.125% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -632.313% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -79.551% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | 45.963% |
| AlloVir, Inc. | -190.41 Million USD | -24.931% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -15.889% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -736.117% |
| Bicycle Therapeutics plc | -180.66 Million USD | -31.676% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -32.861% |
| ChromaDex Corporation | -4.93 Million USD | -4717.578% |
| Chimerix, Inc. | -82.09 Million USD | -189.776% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -433.35% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -133.068% |
| CRISPR Therapeutics AG | -153.61 Million USD | -54.868% |
| Precision BioSciences, Inc. | -61.31 Million USD | -287.958% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -47.825% |
| Fortress Biotech, Inc. | -60.63 Million USD | -292.322% |
| Fortress Biotech, Inc. | -60.63 Million USD | -292.322% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -191.606% |
| ImmuCell Corporation | -5.77 Million USD | -4019.629% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -110.597% |
| Immix Biopharma, Inc. | -15.42 Million USD | -1442.145% |
| Incyte Corporation | 597.59 Million USD | 139.808% |
| Innoviva, Inc. | 179.72 Million USD | 232.367% |
| IO Biotech, Inc. | -86.08 Million USD | -176.352% |
| Jaguar Health, Inc. | -41.3 Million USD | -476.01% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -55.493% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 556.134% |
| ContextLogic Inc. | -317 Million USD | 24.955% |
| MiMedx Group, Inc. | 67.43 Million USD | 452.751% |
| MEI Pharma, Inc. | 17.77 Million USD | 1438.126% |
| NextCure, Inc. | -62.72 Million USD | -279.274% |
| Onconetix, Inc. | -37.4 Million USD | -535.91% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -502.579% |
| Opthea Limited | -220.24 Million USD | -8.014% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -365.005% |
| Vaxcyte, Inc. | -402.26 Million USD | 40.862% |
| PDS Biotechnology Corporation | -42.94 Million USD | -453.982% |
| Precigen, Inc. | -95.9 Million USD | -148.052% |
| Pharming Group N.V. | -10.54 Million USD | -2155.328% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -18.007% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -869.287% |
| PureTech Health plc | -65.69 Million USD | -262.105% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -848.117% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -12.097% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -877.399% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | 7.733% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -773.383% |
| Acelyrin, Inc. | -381.64 Million USD | 37.666% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -1896558.532% |
| Summit Therapeutics Inc. | -614.92 Million USD | 61.314% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -597.61% |
| Senti Biosciences, Inc. | -92.91 Million USD | -156.021% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -127.215% |
| Elevation Oncology, Inc. | -45.7 Million USD | -420.506% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -576.983% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -1719.878% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -3458.594% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -710.204% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -2698.4% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -313.632% |
| Seer, Inc. | -86.27 Million USD | -175.73% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -255.089% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -261.73% |
| ESSA Pharma Inc. | -26.58 Million USD | -794.925% |
| GlycoMimetics, Inc. | -36.89 Million USD | -544.704% |
| GT Biopharma, Inc. | -7.59 Million USD | -3031.394% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | 1.437% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -358.145% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 433.135% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -337.125% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -384.308% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -2291.416% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 58.472% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -6530.212% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -365.925% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | 3.136% |
| Aptose Biosciences Inc. | -51.2 Million USD | -364.569% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -142.011% |
| Soligenix, Inc. | -6.14 Million USD | -3774.002% |
| Century Therapeutics, Inc. | -136.67 Million USD | -74.059% |
| Kura Oncology, Inc. | -152.63 Million USD | -55.861% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -166.641% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -2157.468% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 42169.783% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -41708.787% |
| Autolus Therapeutics plc | -208.38 Million USD | -14.161% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -230.874% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -236.029% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -997.896% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -5.612% |
| GRI Bio, Inc. | -13.03 Million USD | -1724.745% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -5653.719% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -91.719% |
| IGM Biosciences, Inc. | -246.41 Million USD | 3.459% |
| INmune Bio, Inc. | -30 Million USD | -692.762% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -115.172% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -463.808% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -1390.397% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -1406.124% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -298.579% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -135.148% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | 13.847% |
| Verastem, Inc. | -87.36 Million USD | -172.29% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -339.012% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -47.451% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -103.923% |
| Histogen Inc. | -10.62 Million USD | -2139.827% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -1565.123% |
| Surrozen, Inc. | -43.04 Million USD | -452.697% |
| Organovo Holdings, Inc. | -14.67 Million USD | -1521.512% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -4576.443% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -354.522% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -841.662% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -783.109% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -2746.59% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -57.456% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -386.228% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -700.31% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -2183.536% |
| Apollomics, Inc. | -172.6 Million USD | -37.828% |
| Amarin Corporation plc | -59.11 Million USD | -302.443% |
| Mesoblast Limited | -87.95 Million USD | -170.467% |
| Turnstone Biologics Corp. | -55.2 Million USD | -330.964% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -61.873% |
| Synaptogenix, Inc. | -6.03 Million USD | -3839.585% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -1367.744% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -204.912% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -4864.911% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -2731.307% |
| Exelixis, Inc. | 207.76 Million USD | 214.501% |
| Better Therapeutics, Inc. | -39.76 Million USD | -498.32% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -65.262% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 54.998% |
| NLS Pharmaceutics AG | -12.17 Million USD | -1854.415% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -2951.975% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -673.658% |
| Gritstone bio, Inc. | -138.49 Million USD | -71.776% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -269.025% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -5847.374% |
| Avid Bioservices, Inc. | -140.75 Million USD | -69.014% |
| Insmed Incorporated | -749.56 Million USD | 68.263% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -1466.16% |
| MediWound Ltd. | -6.71 Million USD | -3442.168% |
| OmniAb, Inc. | -50.61 Million USD | -369.966% |
| Alector, Inc. | -130.39 Million USD | -82.445% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -109.184% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -358.835% |
| Zai Lab Limited | -334.62 Million USD | 28.907% |
| Revance Therapeutics, Inc. | -323.98 Million USD | 26.573% |
| Aura Biosciences, Inc. | -76.4 Million USD | -211.344% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -1.389% |
| Immunic, Inc. | -93.61 Million USD | -154.126% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -75.058% |
| Veracyte, Inc. | -74.4 Million USD | -219.73% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -2999.348% |
| FibroGen, Inc. | -284.23 Million USD | 16.304% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -806.877% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -3297.54% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -1163.186% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 157.347% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -954.72% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 582.824% |
| TG Therapeutics, Inc. | 12.67 Million USD | 1977.304% |
| Galecto, Inc. | -38.34 Million USD | -520.334% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -1160.956% |
| Fortrea Holdings Inc. | -3.4 Million USD | -6896.824% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -87.843% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -1266.332% |
| XBiotech Inc. | -24.55 Million USD | -868.734% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -269.025% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -279.534% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -141.696% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -1010.244% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -331.018% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 60.785% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -248.534% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -417738.199% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -5.011% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -968.336% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -8.275% |
| NexImmune, Inc. | -32.34 Million USD | -635.497% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -4399.928% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -1593.676% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 106.017% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -882.172% |
| Scopus BioPharma Inc. | -11.6 Million USD | -1949.057% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -103.678% |
| Ainos, Inc. | -13.77 Million USD | -1627.542% |
| Pluri Inc. | -20.88 Million USD | -1038.893% |
| Prothena Corporation plc | -147.02 Million USD | -61.8% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -108.914% |
| Celularity Inc. | -196.29 Million USD | -21.191% |
| Rallybio Corporation | -74.56 Million USD | -219.044% |
| Cue Biopharma, Inc. | -50.73 Million USD | -368.91% |
| MeiraGTx Holdings plc | -84.02 Million USD | -183.114% |
| Omeros Corporation | -117.81 Million USD | -101.923% |
| Humacyte, Inc. | -110.77 Million USD | -114.75% |
| Immunocore Holdings plc | -55.28 Million USD | -330.286% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -1222.798% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -937.425% |
| Blueprint Medicines Corporation | -506.98 Million USD | 53.077% |
| CalciMedica, Inc. | -34.35 Million USD | -592.412% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -251.521% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -68.235% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -43.491% |
| Sana Biotechnology, Inc. | -283.25 Million USD | 16.015% |
| Pulmatrix, Inc. | -14.12 Million USD | -1584.668% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -575.926% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -187.872% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | 50.562% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -126.843% |
| Cytokinetics, Incorporated | -526.24 Million USD | 54.794% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -559.62% |
| Nutriband Inc. | -5.48 Million USD | -4236.889% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -488.55% |
| Vor Biopharma Inc. | -117.86 Million USD | -101.838% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 105.47% |
| Evogene Ltd. | -23.87 Million USD | -896.239% |
| ProKidney Corp. | -35.46 Million USD | -570.723% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -98.636% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -2932.252% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 63.014% |
| CorMedix Inc. | -46.33 Million USD | -413.371% |
| BioLineRx Ltd. | -60.61 Million USD | -292.47% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -133.814% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -479.292% |
| Atai Life Sciences N.V. | -40.22 Million USD | -491.418% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -194.968% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -215.001% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | 18.583% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -753.394% |
| MediciNova, Inc. | -8.57 Million USD | -2675.378% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -92.974% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -2739.88% |
| GeoVax Labs, Inc. | -25.96 Million USD | -816.14% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | 0.563% |
| Biomea Fusion, Inc. | -117.25 Million USD | -102.884% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 62.035% |
| Mereo BioPharma Group plc | -29.46 Million USD | -707.344% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -55.321% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -13.628% |
| Absci Corporation | -110.56 Million USD | -115.158% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -689.028% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -135.917% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -0.829% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 1789.094% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -23.284% |
| Allakos Inc. | -185.7 Million USD | -28.105% |
| Imunon, Inc. | -19.51 Million USD | -1119.023% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -144.405% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 324.13% |
| BioAtla, Inc. | -123.46 Million USD | -92.684% |
| NLS Pharmaceutics AG | -12.17 Million USD | -1854.415% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -1379.612% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | 27.309% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -543.839% |
| XOMA Corporation | -40.83 Million USD | -482.626% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -133.525% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -100.731% |
| aTyr Pharma, Inc. | -50.38 Million USD | -372.111% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -171.322% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -56.756% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -0.066% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -577.388% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -2839.864% |
| Akari Therapeutics, Plc | -10 Million USD | -2277.018% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -353248.682% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 184.48% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -3469.326% |
| UroGen Pharma Ltd. | -102.24 Million USD | -132.671% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -122.76% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -2958.845% |
| Orgenesis Inc. | -55.36 Million USD | -329.71% |
| Entera Bio Ltd. | -8.88 Million USD | -2576.252% |
| GH Research PLC | -35.58 Million USD | -568.48% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -1041.516% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -207.402% |
| Xencor, Inc. | -126.08 Million USD | -88.673% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -6217.335% |
| Replimune Group, Inc. | -215.79 Million USD | -10.24% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -1018.621% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 9581.546% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -3469.326% |
| Portage Biotech Inc. | -75.33 Million USD | -215.762% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -2739.88% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -146.125% |
| OncoCyte Corporation | -27.78 Million USD | -756.312% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -1673.036% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -2039.024% |
| Purple Biotech Ltd. | -19.88 Million USD | -1096.64% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -3289.258% |
| scPharmaceuticals Inc. | -54.81 Million USD | -334.03% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -1258.906% |
| HilleVax, Inc. | -123.56 Million USD | -92.522% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -2253.735% |
| Tharimmune, Inc. | -9.31 Million USD | -2452.737% |
| Genprex, Inc. | -30.86 Million USD | -670.863% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -0.834% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -690.496% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -13249.719% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -4391.906% |
| OKYO Pharma Limited | -16.82 Thousand USD | -1413781.106% |
| Savara Inc. | -54.69 Million USD | -334.919% |
| Curis, Inc. | -47.41 Million USD | -401.744% |
| Daré Bioscience, Inc. | -30.16 Million USD | -688.73% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -1440.244% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -4171.718% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -697.894% |
| BeiGene, Ltd. | -881.7 Million USD | 73.019% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -1017.179% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | 45.484% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -201.301% |
| Erasca, Inc. | -125.04 Million USD | -90.25% |
| bluebird bio, Inc. | -211.91 Million USD | -12.259% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -4657.367% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 241.902% |
| DBV Technologies S.A. | -72.72 Million USD | -227.107% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -4657.367% |
| Moderna, Inc. | -4.71 Billion USD | 94.954% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -492.405% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -4077.942% |
| Molecular Templates, Inc. | -8.12 Million USD | -2828.262% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -293.939% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -113.549% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -75.758% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -396.446% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -68.206% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -23.638% |
| MacroGenics, Inc. | -9.05 Million USD | -2526.319% |
| RenovoRx, Inc. | -10.23 Million USD | -2224.98% |
| Adicet Bio, Inc. | -142.65 Million USD | -66.757% |
| Prime Medicine, Inc. | -198.13 Million USD | -20.067% |
| Aditxt, Inc. | -32.38 Million USD | -634.669% |
| Adagene Inc. | -18.94 Million USD | -1155.607% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3153.57% |
| Quantum-Si incorporated | -95.96 Million USD | -147.907% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -99.861% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -1531.882% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 279.772% |
| SciSparc Ltd. | -5.12 Million USD | -4544.514% |
| Vericel Corporation | -3.18 Million USD | -7376.179% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -197724.605% |
| Minerva Neurosciences, Inc. | -30 Million USD | -692.832% |
| Generation Bio Co. | -126.61 Million USD | -87.891% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -226.367% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -188.557% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | 9.25% |
| Invivyd, Inc. | -198.64 Million USD | -19.759% |
| Relay Therapeutics, Inc. | -341.97 Million USD | 30.435% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -2638.617% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 1143.111% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -2309.277% |
| 2seventy bio, Inc. | -217.57 Million USD | -9.34% |
| ADMA Biologics, Inc. | -28.23 Million USD | -742.424% |
| Clene Inc. | -49.5 Million USD | -380.551% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -967.377% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -381.232% |
| GeoVax Labs, Inc. | -25.96 Million USD | -816.14% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | 27.487% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -631.01% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 1147.06% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -140.801% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -218.233% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -47.938% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 61.322% |
| Evaxion Biotech A/S | -22.12 Million USD | -975.218% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -194.654% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -18.906% |
| Trevena, Inc. | -40.28 Million USD | -490.464% |
| Surrozen, Inc. | -43.04 Million USD | -452.697% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -244.103% |
| Cingulate Inc. | -23.53 Million USD | -910.803% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -3341.725% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -496.819% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -2985.23% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -163.709% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -288.167% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -299.798% |
| Clearmind Medicine Inc. | -11.95 Million USD | -1889.89% |
| Kronos Bio, Inc. | -112.67 Million USD | -111.135% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -243.789% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -9379648.682% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -176.957% |
| Statera Biopharma, Inc. | -174.4 Million USD | -36.4% |
| ImmunityBio, Inc. | -583.19 Million USD | 59.209% |
| Korro Bio, Inc. | -81.17 Million USD | -193.072% |
| Kineta, Inc. | -14.09 Million USD | -1587.297% |
| BioVie Inc. | -32.12 Million USD | -640.623% |
| Codexis, Inc. | -76.24 Million USD | -212.03% |
| Celularity Inc. | -196.29 Million USD | -21.191% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -10.89% |
| Celcuity Inc. | -63.77 Million USD | -272.994% |
| Virax Biolabs Group Limited | -6.73 Million USD | -3432.943% |
| Cibus, Inc. | -267.62 Million USD | 11.111% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -489.922% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -564.299% |
| IN8bio, Inc. | -30 Million USD | -692.788% |
| Kodiak Sciences Inc. | -260.49 Million USD | 8.676% |
| Annexon, Inc. | -134.23 Million USD | -77.218% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -103.04% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -288.535% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -654.159% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | 35.053% |
| Eyenovia, Inc. | -27.26 Million USD | -772.643% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 1201.811% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -44365.794% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -211.361% |
| Arcellx, Inc. | -70.69 Million USD | -236.529% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -474.05% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -77.775% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -691.997% |
| Moolec Science SA | -51.78 Million USD | -359.35% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -354.244% |
| Geron Corporation | -184.12 Million USD | -29.2% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -466.76% |
| Royalty Pharma plc | 1.13 Billion USD | 120.963% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -74.977% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -2575.408% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -1019.848% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -38.575% |
| Humacyte, Inc. | -110.77 Million USD | -114.75% |
| Structure Therapeutics Inc. | -89.62 Million USD | -165.445% |
| 89bio, Inc. | -142.18 Million USD | -67.307% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -244.971% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -2192.493% |
| Genelux Corporation | -28.29 Million USD | -740.697% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -718.483% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -34.312% |
| Notable Labs, Ltd. | -11.26 Million USD | -2011.967% |
| Liquidia Corporation | -78.5 Million USD | -203.039% |
| Mustang Bio, Inc. | -51.6 Million USD | -361.013% |
| Immunovant, Inc. | -259.33 Million USD | 8.269% |
| Quantum-Si incorporated | -95.96 Million USD | -147.907% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -226.555% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -1127.45% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -147.83% |
| Acasti Pharma Inc. | -12.85 Million USD | -1750.868% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -959.282% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -1390.397% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -30.428% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -5430.421% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -1807.715% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -706.66% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -510.167% |
| PepGen Inc. | -78.62 Million USD | -202.561% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -699.127% |
| United Therapeutics Corporation | 984.8 Million USD | 124.156% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -968.697% |
| Solid Biosciences Inc. | -96.01 Million USD | -147.765% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -4864.911% |
| Immuneering Corporation | -53.47 Million USD | -344.894% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -4576.443% |
| Silo Pharma, Inc. | -3.7 Million USD | -6328.327% |
| Belite Bio, Inc | -31.63 Million USD | -652.061% |
| XOMA Corporation | -40.83 Million USD | -482.626% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -337.583% |
| Bionomics Limited | -15.49 Billion USD | 98.464% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -183.255% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -715.9% |
| uniQure N.V. | -308.47 Million USD | 22.882% |
| Cassava Sciences, Inc. | -97.21 Million USD | -144.702% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3153.57% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -92.734% |
| Forte Biosciences, Inc. | -31.47 Million USD | -655.789% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -2800.52% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -718.398% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -44365.794% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -806.877% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -1343.082% |
| Altimmune, Inc. | -88.44 Million USD | -168.966% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -56.937% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -715.9% |
| Compugen Ltd. | -18.75 Million USD | -1168.487% |
| Peak Bio, Inc. | -1259.26 USD | -18891312.417% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -416.606% |
| Benitec Biopharma Inc. | -21.75 Million USD | -993.706% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | 29.782% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -186.776% |
| Zura Bio Limited | -60.36 Million USD | -294.122% |
| PolyPid Ltd. | -23.86 Million USD | -896.824% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -1412.154% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -186.776% |
| Instil Bio, Inc. | -156.08 Million USD | -52.41% |
| argenx SE | -295.05 Million USD | 19.373% |
| Immunome, Inc. | -106.8 Million USD | -122.733% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -459.825% |
| Verona Pharma plc | -54.36 Million USD | -337.551% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -138.09% |
| Shattuck Labs, Inc. | -87.29 Million USD | -172.506% |
| CervoMed Inc. | -2.17 Million USD | -10853.311% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -90.846% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -1686.512% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -446.188% |
| Moolec Science SA | -51.78 Million USD | -359.35% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -1375655.925% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -76.063% |
| AnaptysBio, Inc. | -163.61 Million USD | -45.394% |
| Design Therapeutics, Inc. | -66.86 Million USD | -255.796% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -192.2% |
| NeurAxis, Inc. | -14.62 Million USD | -1526.425% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -527.982% |
| Lumos Pharma, Inc. | -34.03 Million USD | -598.983% |
| Achilles Therapeutics plc | -69.66 Million USD | -241.48% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -138.09% |
| 180 Life Sciences Corp. | -19.93 Million USD | -1093.332% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 8006.567% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -9379648.682% |
| Nutriband Inc. | -5.48 Million USD | -4236.889% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -136.245% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -389.419% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -208.586% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -600.3% |
| MoonLake Immunotherapeutics | -36 Million USD | -560.678% |
| Palisade Bio, Inc. | -12.3 Million USD | -1834.081% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -464.742% |
| Beam Therapeutics Inc. | -132.52 Million USD | -79.505% |
| Neurogene Inc. | -36.31 Million USD | -555.043% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -45.575% |
| AEON Biopharma, Inc. | -52.55 Million USD | -352.645% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -142.383% |
| Sesen Bio, Inc. | -19.88 Million USD | -1096.399% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -232.326% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -1801.023% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | 46.425% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -113.23% |
| Athira Pharma, Inc. | -117.67 Million USD | -102.165% |
| Vaccinex, Inc. | -20.25 Million USD | -1074.717% |
| HCW Biologics Inc. | -24.99 Million USD | -851.786% |
| XOMA Corporation | -40.83 Million USD | -482.626% |
| Nektar Therapeutics | -276.05 Million USD | 13.825% |
| Arvinas, Inc. | -367.3 Million USD | 35.232% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -353248.682% |
| Merus N.V. | -154.93 Million USD | -53.539% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -144.172% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -657.98% |
| Rezolute, Inc. | -68.45 Million USD | -247.496% |
| Clene Inc. | -49.5 Million USD | -380.551% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -1442.402% |
| BeyondSpring Inc. | -21.02 Million USD | -1031.418% |
| Synlogic, Inc. | -57.28 Million USD | -315.3% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -1898.924% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -2097.414% |
| Peak Bio, Inc. | -1259.26 USD | -18891312.417% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -536.62% |
| Krystal Biotech, Inc. | 10.93 Million USD | 2276.107% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -66.243% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | 26.826% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -5050.331% |
| MannKind Corporation | -11.93 Million USD | -1892.729% |
| Ikena Oncology, Inc. | -68.16 Million USD | -248.989% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -1032.01% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -155.982% |
| Gossamer Bio, Inc. | -179.81 Million USD | -32.297% |
| CohBar, Inc. | -11.96 Million USD | -1888.711% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -822.491% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -689.028% |
| Legend Biotech Corporation | -518.25 Million USD | 54.097% |
| Mural Oncology plc | -207.44 Million USD | -14.676% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -91.671% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -1200.687% |
| Disc Medicine, Inc. | -76.42 Million USD | -211.259% |
| Champions Oncology, Inc. | -7.27 Million USD | -3169.544% |
| REGENXBIO Inc. | -263.49 Million USD | 9.716% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -2141.499% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -400.773% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -526.304% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -137.505% |
| Vaxart, Inc. | -82.46 Million USD | -188.476% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 71375.726% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -533.66% |
| Cellectis S.A. | -101.05 Million USD | -135.399% |
| Longeveron Inc. | -21.41 Million USD | -1010.97% |
| Repare Therapeutics Inc. | -93.79 Million USD | -153.627% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 55.615% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -234.264% |
| Revolution Medicines, Inc. | -436.36 Million USD | 45.484% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -3520.332% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -671.775% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -243.115% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -267.503% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -2324.748% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 106.572% |
| Denali Therapeutics Inc. | -145.22 Million USD | -63.81% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -197724.605% |
| Veru Inc. | -93.15 Million USD | -155.379% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -780.136% |
| Cingulate Inc. | -23.53 Million USD | -910.803% |
| Passage Bio, Inc. | -102.06 Million USD | -133.086% |
| Context Therapeutics Inc. | -23.96 Million USD | -892.697% |
| Exicure, Inc. | -16.91 Million USD | -1306.48% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -25.924% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -529.944% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -3555.757% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -28.814% |
| Nuvalent, Inc. | -126.21 Million USD | -88.476% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -2162.265% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -173.82% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -678.85% |
| OmniAb, Inc. | -50.61 Million USD | -369.966% |
| Anew Medical, Inc. | 1.34 Million USD | 17772.356% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -1382.655% |
| Lipocine Inc. | -16.35 Million USD | -1354.812% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -258.303% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -273.603% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -463.808% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -395.949% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -1099.597% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 56.067% |
| Ocugen, Inc. | -63.07 Million USD | -277.139% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -148.498% |
| Q32 Bio Inc. | -112.96 Million USD | -110.597% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -1283.737% |
| Alumis Inc. Common Stock | -154.99 Million USD | -53.486% |
| Equillium, Inc. | -13.33 Million USD | -1683.967% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -294.083% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -2878.178% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -1161.944% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -302.647% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -107.717% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -1194.442% |
| Dominari Holdings Inc. | -22.88 Million USD | -939.647% |
| Edesa Biotech, Inc. | -8.37 Million USD | -2740.7% |
| vTv Therapeutics Inc. | -20.25 Million USD | -1074.775% |
| Bio-Techne Corporation | 168.1 Million USD | 241.514% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | 32.434% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 284.623% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -95.262% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -527.038% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -111.193% |
| Nkarta, Inc. | -117.5 Million USD | -102.46% |
| BioCardia, Inc. | -11.57 Million USD | -1955.933% |
| Iterum Therapeutics plc | -38.37 Million USD | -519.979% |